These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2805845)

  • 21. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ; Rodriguez FC; Benavente MC
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
    Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.
    Serra C; Loi G; Saddi B; Pautasso M; Manzin A
    J Clin Microbiol; 2007 May; 45(5):1663-5. PubMed ID: 17360837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rapidly growing mycobacteria--Mycobacterium fortuitum and Mycobacterium chelonei.
    Brown TH
    Infect Control; 1985 Jul; 6(7):283-8. PubMed ID: 3891655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
    Wallace RJ; Bedsole G; Sumter G; Sanders CV; Steele LC; Brown BA; Smith J; Graham DR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):65-70. PubMed ID: 2327761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections.
    Yew WW; Kwan SY; Wong PC; Lee J
    Tubercle; 1990 Jun; 71(2):131-3. PubMed ID: 2219463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of Nocardia asteroides sternotomy infection treated with ofloxacin and a review of other active antimicrobial agents.
    Yew WW; Wong PC; Kwan SY; Chan CY; Li MS
    J Infect; 1991 Nov; 23(3):297-302. PubMed ID: 1753139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical wound infection following open humeral fracture caused by Mycobacterium houstonense: a case report.
    Tian L; Zhang Z; Chen Z; Sun Z
    BMC Infect Dis; 2019 Apr; 19(1):333. PubMed ID: 31014284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex.
    Hoffman PC; Fraser DW; Robicsek F; O'Bar PR; Mauney CU
    J Infect Dis; 1981 Apr; 143(4):533-42. PubMed ID: 7240799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive surgical management of cutaneous Mycobacterium fortuitum infection.
    Madjar DD; Carvallo E; Proper SA; Fenske NA
    J Dermatol Surg Oncol; 1985 Jul; 11(7):708-12. PubMed ID: 4008739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery.
    Wallace RJ; Musser JM; Hull SI; Silcox VA; Steele LC; Forrester GD; Labidi A; Selander RK
    J Infect Dis; 1989 Apr; 159(4):708-16. PubMed ID: 2926161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortitis caused by Mycobacterium fortuitum.
    Schlossberg D; Aaron T
    Arch Intern Med; 1991 May; 151(5):1010-1. PubMed ID: 2025125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.
    Collins CH; Yates MD; Uttley AH
    J Hyg (Lond); 1985 Dec; 95(3):619-21. PubMed ID: 2936800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty.
    Wolfe JM; Moore DF
    J Clin Microbiol; 1992 Apr; 30(4):1036-8. PubMed ID: 1572963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of pulmonaly bulla infection with Mycobacterium fortuitum].
    Hisamori S; Oida K; Taguchi Y; Tanaka E; Inoue T; Katoh K; Sakuramoto M; Minaguchi M; Maeda Y; Maniwa K; Terada K; Ishimaru H; Hata K
    Kansenshogaku Zasshi; 2003 Jun; 77(6):451-5. PubMed ID: 12872695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments.
    Entwistle FM; Coote PJ
    J Med Microbiol; 2018 Apr; 67(4):585-597. PubMed ID: 29458557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.